Interaction of bladder glycoprotein GP51 with uropathogenic bacteria.
OBJECTIVE
A major component of bladder surface mucin is a glycoprotein GP51 (molecular weight 51 kD.). GP51, which has previously been isolated from rabbit mucosa, appears to function as part of the defense mechanism in an in vivo infection model. GP51 coats the epithelium and is secreted into the urine, as detected by immunohistochemical testing and enzyme-linked immunosorbent assay (ELISA). Increased urinary GP51 occurs during urinary tract infection. To elucidate the role of GP51 as a component of the primary defense mechanism we studied interactions with uropathogenic bacterial isolates and urine from symptomatic patients with urinary tract infection.


METHODS
ELISA was performed to demonstrate the binding of GP51 and various uropathogens. Immunochemical studies were done using monoclonal antibodies to GP51 to determine the interaction of GP51 with certain uropathogenic isolates, including Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Proteus vulgaris, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, S. epidermidis and Streptococcus faecalis. Infected urinary sediments and uropathogenic bacterial cultures were examined by immunocytochemical testing to localize GP51. Antigen inhibition ELISA was done to quantitate urinary GP51 in the urine of 17 normal controls and 19 patients with urinary tract infection.


RESULTS
ELISA revealed that GP51 binds to a wide spectrum of gram-positive and gram-negative uropathogens in semiquantitative fashion. Immunochemical methods confirmed that purified GP51 binds to bacteria, encapsulating and aggregating the bacteria. Clinical specimens showed GP51 localized to bacteria and uroepithelial cells. We observed a significant increase in urinary GP51 in urinary tract infection compared to uninfected urine (p = 0.0003).


CONCLUSIONS
These studies suggest that GP51, a component of bladder mucin, may be a strategic factor in the primary defense mechanism of the bladder.
Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
D E
DE
Shupp Byrne
J F
JF
Sedor
M
M
Soroush
P A
PA
McCue
S G
SG
Mulholland
D000911:Antibodies, Monoclonal; D004797:Enzyme-Linked Immunosorbent Assay; D006023:Glycoproteins / Q000652:urine*; D006801:Humans; D007150:Immunohistochemistry; D009077:Mucins / Q000502:physiology; D014552:Urinary Tract Infections / Q000382:microbiology*
D000911:Antibodies, Monoclonal; D006023:Glycoproteins; D009077:Mucins